Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Jackson

Showing results (231-240 of 251) with videos related to

Pageof 26
Sort By:
The American Journal of Medicine|January 16, 2014
All men with vasculogenic erectile dysfunction require a cardiovascular workupMartin Miner, Ajay Nehra, Graham Jackson, et al.
Mayo Clinic Proceedings|August 7, 2012
The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular diseaseAjay Nehra, Graham Jackson, Martin Miner, et al.
The American Journal of Cardiology|January 3, 2006
Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference)John B Kostis, Graham Jackson, Raymond Rosen, et al.
The American Journal of Cardiology|July 16, 2005
Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference)John B Kostis, Graham Jackson, Raymond Rosen, et al.
BMJ Open|June 2, 2022
<i>F</i>railty-adjusted therapy <i>i</i>n <i>T</i>ransplant <i>N</i>on-<i>E</i>ligible patient<i>s</i> with newly diagno<i>s</i>ed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III trialAmy Beth Coulson, Kara-Louise Royle, Charlotte Pawlyn, et al.
Leukemia|December 2, 2020
Copy number evolution and its relationship with patient outcome-an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trialJames Croft, Sidra Ellis, Amy L Sherborne, et al.
The Journal of Sexual Medicine|January 21, 2006
Pharmacotherapy for erectile dysfunctionHarin Padma-Nathan, George Christ, Ganesan Adaikan, et al.
Blood|October 31, 2018
Subclonal <i>TP53</i> copy number is associated with prognosis in multiple myelomaVallari Shah, David C Johnson, Amy L Sherborne, et al.
American Journal of Hematology|June 18, 2026
The Changing Landscape of Maintenance Therapy in Newly Diagnosed Multiple Myeloma: A Systematic Review With Network Meta-Analysis of the European Myeloma Network (EMN)Heinz Ludwig, Evangelos Terpos, Francesca Gay, et al.
BMJ Open|November 17, 2022
Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trialKara-Louise Royle, Amy Beth Coulson, Karthik Ramasamy, et al.
Pageof 26

Showing results (231-240 of 251) with videos related to

Sort By:
Pageof 26
The American Journal of Medicine|January 16, 2014
All men with vasculogenic erectile dysfunction require a cardiovascular workupMartin Miner, Ajay Nehra, Graham Jackson, et al.
Mayo Clinic Proceedings|August 7, 2012
The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular diseaseAjay Nehra, Graham Jackson, Martin Miner, et al.
The American Journal of Cardiology|January 3, 2006
Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference)John B Kostis, Graham Jackson, Raymond Rosen, et al.
The American Journal of Cardiology|July 16, 2005
Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference)John B Kostis, Graham Jackson, Raymond Rosen, et al.
BMJ Open|June 2, 2022
<i>F</i>railty-adjusted therapy <i>i</i>n <i>T</i>ransplant <i>N</i>on-<i>E</i>ligible patient<i>s</i> with newly diagno<i>s</i>ed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III trialAmy Beth Coulson, Kara-Louise Royle, Charlotte Pawlyn, et al.
Leukemia|December 2, 2020
Copy number evolution and its relationship with patient outcome-an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trialJames Croft, Sidra Ellis, Amy L Sherborne, et al.
The Journal of Sexual Medicine|January 21, 2006
Pharmacotherapy for erectile dysfunctionHarin Padma-Nathan, George Christ, Ganesan Adaikan, et al.
Blood|October 31, 2018
Subclonal <i>TP53</i> copy number is associated with prognosis in multiple myelomaVallari Shah, David C Johnson, Amy L Sherborne, et al.
American Journal of Hematology|June 18, 2026
The Changing Landscape of Maintenance Therapy in Newly Diagnosed Multiple Myeloma: A Systematic Review With Network Meta-Analysis of the European Myeloma Network (EMN)Heinz Ludwig, Evangelos Terpos, Francesca Gay, et al.
BMJ Open|November 17, 2022
Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trialKara-Louise Royle, Amy Beth Coulson, Karthik Ramasamy, et al.
Pageof 26